Arch Therapeutics Appoints Senior Management Team Members
08 juil. 2013 09h00 HE | Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Jul 8, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life science company and developer of AC5™, a novel product aimed at...